Premium
Self perception affecting adherence to drug regimen following renal transplantation
Author(s) -
Trevitt R.,
Whittaker C.,
Ball E.A.
Publication year - 1999
Publication title -
edtna‐erca journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.381
H-Index - 27
eISSN - 1755-6686
pISSN - 1019-083X
DOI - 10.1111/j.1755-6686.1999.tb00039.x
Subject(s) - immunosuppression , azathioprine , tacrolimus , medicine , prednisolone , regimen , transplantation , drug , kidney transplantation , pharmacology , disease
Summary The patient, a chronic cannabis user, found it increasingly difficult to tolerate the side effects of the medication on her appearance. Rejection in the early post‐transplant period meant that immunosuppression could not be further reduced. We were able to avoid a catastrophic self‐initiated cut in immunosuppression, and withdrawal of steroids was carried out according to a schedule supervised by the clinic. Cellular rejection resulted and was treated with IV methyl prednisolone and conversion from cyclosporin micro‐emulsion (Neoral®, Novartis) to tacrolimus (Prograf®, Fujisawa) and from azathioprine to mycophenolate mofetil (CellCept®, Roche).